RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
-7.04%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$4.74B
AUM Growth
+$4.74B
(-9.8%)
Cap. Flow
+$299M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
55.75%
Holding
72
New
10
Increased
16
Reduced
6
Closed
5
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$106M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$100M |
| 3 |
Taysha Gene Therapies
TSHA
|
$53.4M |
| 4 |
Apogee Therapeutics
APGE
|
$45.6M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$37.4M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$103M |
| 2 |
Intuitive Surgical
ISRG
|
$58.1M |
| 3 |
Illumina
ILMN
|
$25.8M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$24.8M |
| 5 |
Maravai LifeSciences
MRVI
|
$19.1M |
Sector Composition
| 1 | Healthcare | 99.97% |
| 2 | Financials | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insmed
INSM
$30.3B
| $47.1M | 0.99% |
1,865,108
+865,108
| +87% | +$21.8M |
|
27
Merus
MRUS
$5.04B
| $47.1M | 0.99% |
1,996,764
+945,871
| +90% | +$22.3M |
|
|
28
Apogee Therapeutics
APGE
$2.27B
| $45.6M | 0.96% |
+2,142,591
| New | +$45.6M |
|
29
Madrigal Pharmaceuticals
MDGL
$9.7B
| $45.2M | 0.95% |
309,485
+87,923
| +40% | +$12.8M |
|
30
Avidity Biosciences
RNA
$6.12B
| $42.7M | 0.9% |
6,689,789
| – | – |
|
31
GH Research
GHRS
$870M
| $33.4M | 0.71% |
3,327,129
+1,158,172
| +53% | +$11.6M |
|
32
MoonLake Immunotherapeutics
MLTX
$3.78B
| $28.5M | 0.6% |
500,000
| – | – |
|
33
Fulcrum Therapeutics
FULC
$353M
| $25.8M | 0.55% |
5,818,804
-245,319
| -4% | -$1.09M |
|
|
34
Illumina
ILMN
$15.2B
| $25.8M | 0.54% |
188,125
-188,125
| -50% | -$25.8M |
|
35
Alkermes
ALKS
$4.95B
| $24.9M | 0.53% |
+889,073
| New | +$24.9M |
|
|
AXNX
36
DELISTED
Axonics, Inc. Common Stock
AXNX
| $24.8M | 0.52% |
442,487
-442,487
| -50% | -$24.8M |
|
|
SWAV
37
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $24.7M | 0.52% |
+124,000
| New | +$24.7M |
|
38
scPharmaceuticals
SCPH
$296M
| $23.5M | 0.5% |
3,297,843
| – | – |
|
39
Roivant Sciences
ROIV
$8.6B
| $18.1M | 0.38% |
1,552,717
| – | – |
|
40
Stoke Therapeutics
STOK
$1.08B
| $17.3M | 0.37% |
4,390,558
| – | – |
|
41
Allurion Technologies
ALUR
$16.5M
| $14.9M | 0.31% |
+3,457,707
| New | +$14.9M |
|
42
Guardant Health
GH
$8.11B
| $14.8M | 0.31% |
500,887
| – | – |
|
43
PMV Pharmaceuticals
PMVP
$82.1M
| $14.6M | 0.31% |
2,375,785
-653,766
| -22% | -$4.01M |
|
44
UroGen Pharma
URGN
$896M
| $12M | 0.25% |
857,464
| – | – |
|
|
CUTR
45
DELISTED
Cutera, Inc.
CUTR
| $11.1M | 0.23% |
1,846,596
| – | – |
|
46
Milestone Pharmaceuticals
MIST
$151M
| $10.1M | 0.21% |
3,256,102
| – | – |
|
|
SLRN
47
DELISTED
ACELYRIN
SLRN
| $9.95M | 0.21% |
978,310
| – | – |
|
48
Immatics
IMTX
$662M
| $9.79M | 0.21% |
845,000
| – | – |
|
49
Outset Medical
OM
$245M
| $8.8M | 0.19% |
808,658
| – | – |
|
50
Mineralys Therapeutics
MLYS
$1.94B
| $8.77M | 0.19% |
922,100
| – | – |
|